rs141391430
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_015602.4(TOR1AIP1):c.428C>T(p.Ser143Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000592 in 1,614,032 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_015602.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOR1AIP1 | NM_015602.4 | c.428C>T | p.Ser143Phe | missense_variant | 1/10 | ENST00000606911.7 | NP_056417.2 | |
TOR1AIP1 | NM_001267578.2 | c.428C>T | p.Ser143Phe | missense_variant | 1/10 | NP_001254507.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOR1AIP1 | ENST00000606911.7 | c.428C>T | p.Ser143Phe | missense_variant | 1/10 | 1 | NM_015602.4 | ENSP00000476687 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152226Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000857 AC: 213AN: 248556Hom.: 2 AF XY: 0.000821 AC XY: 111AN XY: 135264
GnomAD4 exome AF: 0.000585 AC: 855AN: 1461688Hom.: 3 Cov.: 30 AF XY: 0.000587 AC XY: 427AN XY: 727146
GnomAD4 genome AF: 0.000656 AC: 100AN: 152344Hom.: 0 Cov.: 31 AF XY: 0.000537 AC XY: 40AN XY: 74502
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2Y Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 25, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at